Topic: Cancer research
This project will focus on developing adaptive radiotherapy for locally advanced lung, prostate and oligometastatic cancer.
Professor Liu and his team are investigating how particular proteins affect the development and growth of tumours in children with TERT-rearranged neuroblastoma.
This is one of the first studies in Australia and the world looking at the role of gut bacteria in lung cancer development and progression.
Dr Micklethwaite and his team aim to create a new class of CAR T-cells that are capable of recognising and attacking acute myeloid leukaemia cells with a high degree of accuracy.
Professor Maija Kohonen-Corish and her team have been developing crucial evidence on MCC protein alteration with the aim of creating new treatment targets and biomarkers for bowel cancer.
Dr Debbie Watson will develop a potential new treatment strategy using manipulated stem cell transplantation combined with drugs that block development of graft-versus-host disease.
This project aims to develop a way to increase the effectiveness of chemotherapy in pancreatic cancer using a dual treatment approach that targets the production of protective tissue in the tumour.
Dr Wong’s research is focused on the chemical changes in DNA and RNA that are associated with acute myeloid leukaemia.
This project aims to show that certain nerve growth factors (proteins that stimulate the growth of nerves) are effective biomarkers for prostate cancer.
This project will develop methods for upscaling CAR T-cell production in NSW – accelerating the introduction of this cutting-edge therapy and making treatment more affordable.